DopamineReceptors, Dopamine D2Receptors, Dopamine D1Dopamine AgonistsDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D3Dopamine Plasma Membrane Transport ProteinsDopamine AgentsReceptors, Dopamine D5Dopamine Uptake InhibitorsBipolar DisorderDopamine beta-HydroxylaseCorpus StriatumMental DisordersAnxiety DisordersMood DisordersQuinpiroleBenzazepinesRacloprideDiagnostic and Statistical Manual of Mental DisordersNucleus AccumbensSulpirideHaloperidolApomorphineSalicylamidesAttention Deficit Disorder with HyperactivityNeostriatumCocaineLevodopaDepressive Disorder, MajorAmphetamineDopaminergic NeuronsHomovanillic AcidTyrosine 3-MonooxygenaseDopamine and cAMP-Regulated Phosphoprotein 32Depressive DisorderMicrodialysisSubstantia NigraRats, Sprague-DawleySpiperoneBrainObsessive-Compulsive DisorderVentral Tegmental AreaSubstance-Related DisordersAutistic DisorderMesencephalonOxidopamineStress Disorders, Post-TraumaticNeuronsErgolinesBehavior, AnimalPsychotic DisordersCaudate NucleusPhobic DisordersChild Development Disorders, PervasiveMotor Activityalpha-MethyltyrosineDomperidoneDihydroxyphenylalanineParkinsonian DisordersNomifensineFlupenthixolTropanesVesicular Monoamine Transport ProteinsCentral Nervous System StimulantsPutamenAntipsychotic AgentsPrefrontal CortexDose-Response Relationship, DrugBromocriptineSerotoninSchizophreniaConduct DisorderTic DisordersRewardMethamphetaminePsychiatric Status Rating ScalesAnalysis of VarianceBiogenic MonoaminesButaclamolCognition DisordersBasal GangliaNerve Tissue ProteinsMethylphenidateTime FactorsBorderline Personality DisorderImpulse Control DisordersMovement DisordersSomatoform DisordersSleep DisordersNorepinephrineStereotyped BehaviorLimbic SystemCocaine-Related DisordersAntiparkinson AgentsBrain ChemistryCatecholaminesDisease Models, AnimalDextroamphetamine